Nuvation Bio (NUVB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But what's the best way ...

Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor.But what's the best way to find the right combination of ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...

For the most recent quarter, Northern Trust was expected to post earnings of $1.9 per share, but it reported $1.85 per share ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth ...

In the most recent trading session, Energy Transfer LP (ET) closed at $17.75, indicating a -1.22% shift from the previous trading day.

Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, July 7th: Verona Pharma VRNA: This company which is focused on developing and commercializing ...

Zacks.com users have been paying close attention to Morgan Stanley (MS). This makes it worthwhile to examine what the stock has in store.